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March 23, 2010:1278–82ubtype causes coronary vasoconstriction in mice (3,4), reinforcing
ur point that 1-subtype expression is similar in the mouse and
uman heart and that mouse models can be relevant to human
isease. We also believe that our identification of 1D as the major
1-AR subtype in human coronaries (1) and 1A and 1B as the
ajor subtypes in human myocardium (5) will facilitate much
ore precise studies with agonists and antagonists in large animals
nd humans.
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eterminants of Raised Pulse
ressure in Women
ecelja et al. (1) conclude that increased wave reflection, not
rterial stiffness, determines pulse pressure, including central pulse
ressure (cPP), in women. They base this conclusion on regression
nalysis showing that the ratio of femoral to aortic diameter (DFA
assumed an index of central-peripheral artery discontinuity and hence
f wave reflection]) was a significant determinant of pressure aug-
entation (Paug) whereas pulse wave velocity (PWV [a measure of
rterial stiffness]) was not. However, from Table 3 in their article (1),
t appears that DFA accounts for only 2% of variation in Paug. In
ontrast, PWV accounts for 30% of variation in P1.
In analysis of the contribution of P1 and Paug to variance in
PP, the relative contributions (for the whole cohort) were 22%
nd 76%, respectively. We therefore calculate that PWV contrib-
tes 6.6% and DFA 1.5% to cPP variance. From Figure 2 (1), P1
ontributes about two-thirds of total cPP (for the whole cohort).
or the whole group, the proportional contribution to cPP,
herefore, is 0.7% for wave reflection and 20% for arterial (tiffness (assuming PWV and DFA are indeed appropriate surro-
ates and using results from Table 3 [1]).
These analyses suggest an entirely opposite conclusion to the
uthors. We believe their data are actually consistent with the
roposition that arterial stiffness, not wave reflection, is the major
eterminant of both cPP and its variation in this cohort of women;
lack of association between PWV and T1 is also consistent with
his interpretation.
Perhaps the “simple approach” adopted by Cecelja et al. (1) to
ssessing reflected pressure is overly simplistic. The authors could
ot formally decompose central blood pressure into forward and
everse going waves (via reflection coefficient or wave-intensity
nalysis), and there are problems using central T1 to delineate
orward and reverse going waves:
. P1 only represents the full magnitude of ejection wave if any
reflected wave arrives after the peak (i.e., T1 is a local minimum
rather than an inflection point). Peak ejection pressure would
otherwise be lost under the reflected component.
. Paug does not correspond to the magnitude of any reflected
wave; even a small reverse going wave arriving early in ventric-
ular ejection will produce an inflection point interpreted as a
large Paug; similarly, a large wave arriving late may result in a
small Paug. Reflection site and PWV predominantly deter-
mine Paug, not the magnitude of the reflected wave.
. It is well demonstrated that estimated central T1 obtained by
transfer function techniques is unreliable in representing true
central inflection point (2,3).
Among women 60 years of age, Cecelja et al. (1) observed a
mall influence of aortic diameter on P1 with no effect of DFA,
upporting that aortic stiffness and diameter (4) rather than wave
eflection are important in determining PP in this age group in
hom it is an important predictor of cardiovascular risk.
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e thank Drs. Cameron and Dart for their interest in our work
1). The main finding of our study was that augmentation pressure
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March 23, 2010:1278–82PAUG) accounts for the majority of the variance in central pulse
ressure (cPP) and is unrelated to pulse wave velocity (PWV). In
ine with most authorities (including those providing the editorial
ccompanying our paper), we attributed PAUG to wave reflection
2–4). Drs. Cameron and Dart’s “alternate” explanation of our data
s based on the assumption that the ratio of femoral artery to
bdominal aortic diameter (DFA) is a measure of wave reflection.
iven that wave reflection depends on discontinuities in imped-
nce along the arterial tree, DFA could at best be a surrogate
easure of increased impedance due to diameter decrease. How-
ver, DFA cannot be regarded as a measure of wave reflection. Of
ll arterial dimensions measured in our study, PAUG was most
losely related to DFA, and we made the point that this was
onsistent with reflection (as measured by PAUG) being influ-
nced by serial change in diameter.
We acknowledge that PAUG may not be the “best” measure of
ave reflection and the limitations of the transfer function, which
e stressed in our paper. However, we would also point out that
he separation of pressure waves into forward and backward waves
s not without its problems and relies on several assumptions.
ecause PAUG is a major component of cPP, it will be important
o identify the exact determinants of PAUG. Any theoretical
nalysis needs to be confirmed by careful measurement of proper-
ies along the arterial tree during interventions that selectively
odulate potential determinants of PAUG.
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lternative Interpretation
f Mitochondrial Metabolic
hanges in Atrial Tissue of
ype II Diabetic Human Heart
nderson et al. (1) presented an elegant study in which they assessed
he rates of substrate oxidation and reactive oxygen species productionf atrial tissue from diabetic patients with normal ejection fraction
ndergoing coronary artery bypass graft. The authors observed re-
uced mitochondrial respiratory capacity with palmitoyl-L-carnitine
nd glutamate as substrate, but not with pyruvate and succinate, as
ell as augmented reactive oxygen species production in the diabetic
roup when compared with nondiabetic patients. They then sug-
ested that the existence of myocardial insulin resistance may explain
he observed defects in oxidative capacity. However, 3 major concerns
ave not been addressed in the manuscript, which render the
onclusions questionable.
First, the authors refer to the decreased respiratory capacity with
almitoyl-L-carnitine as a defect in fatty acid oxidation, not
onsidering the following interpretation. The authors used gluta-
ate, a complex I substrate, and succinate, a complex II substrate.
ecause glutamate respiration was reduced and succinate was
ormal, a defect may be located at the level of complex I. This
onclusion would be supported by the finding of decreased
espiratory rates of palmitoyl-L-carnitine, but not by normal
yruvate respiration, which also should be reduced in this case. In
nalogy to this reasoning, the conclusion of decreased fatty acid
xidation based on the reduced palmitoyl-L-carnitine–supported
espiration can be challenged by their reduced glutamate respira-
ory measurements, because levels of glutamate and pyruvate
hould be normal. Thus, the conclusion that fatty acid oxidation is
educed, based only in respiratory measurements, is questionable.
Second, the authors suggest that cardiac insulin resistance may
e the cause for the observed alterations and refer to the results
rom Boudina et al. (2) obtained in a cardio-specific insulin
eceptor knockout mouse. To date, there is no consensus regarding
hether cardiac insulin resistance is present in both type I and type
I diabetes, and the authors did not assess the activity of insulin
ignaling cascade in their study. In contrast, ischemic heart disease
as been shown to be accompanied by cardiac insulin resistance
3,4). Considering that all patients including the control group had
oronary artery disease, it is most likely that if cardiac insulin
esistance was present in the diabetic patients, it could be present
n the control group as well and therefore would not explain the
etabolic changes observed.
Third, there were no data regarding the number of compro-
ised vessels in each group. Since type II diabetes is associated
ith increased risk of coronary heart disease (5), it is unclear
hether the differences among groups are related to the extension
f vessel disease.
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